Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,150 | -46,606 | -240,053 | -154,350 | -108,296 |
| Depreciation Amortization | 1,681 | 843 | 3,267 | 2,256 | 1,535 |
| Income taxes - deferred | N/A | N/A | 37,104 | -8,643 | -5,172 |
| Accounts receivable | 2,314 | 1,995 | 47,789 | 51,787 | 49,089 |
| Accounts payable and accrued liabilities | -6,083 | -1,247 | 3,173 | -3,398 | -687 |
| Other Working Capital | -14,742 | -9,923 | 44,271 | 34,090 | 37,932 |
| Other Operating Activity | 23,040 | 10,843 | -14,237 | -7,355 | -24,781 |
| Operating Cash Flow | $-76,940 | $-44,095 | $-118,686 | $-85,613 | $-50,380 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -561 | -531 | -3,216 | -2,870 | -2,228 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -19 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 181 | 0 |
| Investing Cash Flow | $-561 | $-531 | $-3,216 | $-2,689 | $-2,228 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 61,805 | 356 | 773 | N/A | N/A |
| Other Financing Activity | 37,248 | 0 | 73,102 | 72,236 | 73,527 |
| Financing Cash Flow | $99,053 | $356 | $73,875 | $72,236 | $73,527 |
| Exchange Rate Effect | -31 | -43 | 184 | 32 | 150 |
| Beginning Cash Position | 278,598 | 278,598 | 326,441 | 326,441 | 326,441 |
| End Cash Position | 300,119 | 234,285 | 278,598 | 310,407 | 347,510 |
| Net Cash Flow | $21,521 | $-44,313 | $-47,843 | $-16,034 | $21,069 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,940 | -44,095 | -118,686 | -85,613 | -50,380 |
| Capital Expenditure | -561 | -531 | -3,216 | -2,870 | -2,228 |
| Free Cash Flow | -77,501 | -44,626 | -121,902 | -88,483 | -52,608 |